Jiangsu Chinagreen Biological Technology Co Ltd
SZSE:300970
Intrinsic Value
Jiangsu Chinagreen Biological Technology Co., Ltd. engages in the research, development, planting, and sale of edible fungi. [ Read More ]
The intrinsic value of one
Jiangsu Chinagreen Biological Technology Co Ltd
stock under the Base Case scenario is
19.06
CNY.
Compared to the current market price of 12.14 CNY,
Jiangsu Chinagreen Biological Technology Co Ltd
is
Undervalued by 36%.
Jiangsu Chinagreen Biological Technology Co Ltd's market capitalization is 1.4B CNY.
Jiangsu Chinagreen Biological Technology Co Ltd stock price is 12.14 CNY.
Jiangsu Chinagreen Biological Technology Co Ltd stock price (12.14 CNY) is 36% less than its Intrinsic Value (19.06 CNY).
Jiangsu Chinagreen Biological Technology Co Ltd stock price (12.14 CNY) is 42% less than its DCF Value (20.92 CNY). Open DCF Valuation
Jiangsu Chinagreen Biological Technology Co Ltd stock price (12.14 CNY) is 29% less than its Relative Value (17.2 CNY). Open Relative Valuation
Jiangsu Chinagreen Biological Technology Co Ltd.
Jiangsu Chinagreen Biological Technology Co Ltd has positive Operating Income for the last twelve months.
Jiangsu Chinagreen Biological Technology Co Ltd has positive Net Income for the last twelve months.
Jiangsu Chinagreen Biological Technology Co Ltd's ROIC (Return on Invested Capital) has decreased in the last 3 years from 9% to 6%.
Jiangsu Chinagreen Biological Technology Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 6%.
Jiangsu Chinagreen Biological Technology Co Ltd's ROE (Return on Equity) has decreased in the last 3 years from 9% to 6%.
Jiangsu Chinagreen Biological Technology Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 6%.
Jiangsu Chinagreen Biological Technology Co Ltd has positive Gross Profit for the last twelve months.
Jiangsu Chinagreen Biological Technology Co Ltd's Revenue has been growing by 10% per year for the last 3 years.
Jiangsu Chinagreen Biological Technology Co Ltd has positive three-year average ROE (Return on Equity): 6%. The company is efficient at transforming stockholders' equity into net income.
Jiangsu Chinagreen Biological Technology Co Ltd's Revenue has grown by an exceptional 35% over the past 12 months.
Jiangsu Chinagreen Biological Technology Co Ltd's short-term assets (711m CNY) exceed its short-term liabilties (274m CNY).
Jiangsu Chinagreen Biological Technology Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (487m CNY) than debt (204m CNY).
Jiangsu Chinagreen Biological Technology Co Ltd's Altman Z-Score is very high and is equal to 3.65.
Jiangsu Chinagreen Biological Technology Co Ltd has negative Free Cash Flow for the last twelve months.
Jiangsu Chinagreen Biological Technology Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.13.
Jiangsu Chinagreen Biological Technology Co Ltd has negative three-year average ROIC (Return on Invested Capital): -261 951%. The company is not efficient at using invested capital to generate operating income.
Jiangsu Chinagreen Biological Technology Co Ltd's long-term assets (2B CNY) exceed its long-term liabilties (523m CNY).
Valuation Backtest
Jiangsu Chinagreen Biological Technology Co Ltd
Run backtest to discover the historical profit from buying and selling
Jiangsu Chinagreen Biological Technology Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Jiangsu Chinagreen Biological Technology Co Ltd
Balance Sheet Decomposition
Jiangsu Chinagreen Biological Technology Co Ltd
| Current Assets | 710.5m |
| Cash & Short-Term Investments | 487.1m |
| Receivables | 21m |
| Other Current Assets | 202.4m |
| Non-Current Assets | 1.4B |
| Long-Term Investments | 481.9k |
| PP&E | 1.3B |
| Intangibles | 57.8m |
| Other Non-Current Assets | 42.1m |
| Current Liabilities | 273.5m |
| Accounts Payable | 80.4m |
| Accrued Liabilities | 20.5m |
| Short-Term Debt | 24m |
| Other Current Liabilities | 148.6m |
| Non-Current Liabilities | 249.9m |
| Long-Term Debt | 179.7m |
| Other Non-Current Liabilities | 70.2m |
Earnings Waterfall
Jiangsu Chinagreen Biological Technology Co Ltd
|
Revenue
|
974.9m
CNY
|
|
Cost of Revenue
|
-792.4m
CNY
|
|
Gross Profit
|
182.5m
CNY
|
|
Operating Expenses
|
-92.5m
CNY
|
|
Operating Income
|
90m
CNY
|
|
Other Expenses
|
-2.9m
CNY
|
|
Net Income
|
87.1m
CNY
|
Free Cash Flow Analysis
Jiangsu Chinagreen Biological Technology Co Ltd
Profitability Score
Profitability Due Diligence
Jiangsu Chinagreen Biological Technology Co Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
Score
Jiangsu Chinagreen Biological Technology Co Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Jiangsu Chinagreen Biological Technology Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Jiangsu Chinagreen Biological Technology Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Jiangsu Chinagreen Biological Technology Co Ltd
Shareholder Return
Price
Jiangsu Chinagreen Biological Technology Co Ltd
| Average Annual Return | -33.92% |
| Standard Deviation of Annual Returns | 9.14% |
| Max Drawdown | -77% |
| Market Capitalization | 1.4B CNY |
| Shares Outstanding | 117 889 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Jiangsu Chinagreen Biological Technology Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Jiangsu Chinagreen Biological Technology Co., Ltd. engages in the research, development, planting, and sale of edible fungi. The company is headquartered in Suqian, Jiangsu and currently employs 1,829 full-time employees. The company went IPO on 2021-04-12. The firm mainly produces and sells flammulina velutipes and hypsizygus marmoreus (including hypsizygus tessellatus and white beech mushroom). The firm uses a factory model to produce edible fungi. According to the different biological characteristics of each edible fungus, the Company makes comprehensive use of biological engineering technology, engineering equipment technology, ecological environment simulation control technology, automation technology, to create a suitable growth environment for edible fungi, and carries out standardized and intelligent management under controllable environmental conditions.
Contact
IPO
Employees
Officers
The intrinsic value of one
Jiangsu Chinagreen Biological Technology Co Ltd
stock under the Base Case scenario is
19.06
CNY.
Compared to the current market price of 12.14 CNY,
Jiangsu Chinagreen Biological Technology Co Ltd
is
Undervalued by 36%.
You don't have any saved screeners yet
